SELLAS Life Sciences Group Inc

Insider buying spree at Sellas signals confidence in its oncology pipeline, hinting at upcoming clinical breakthroughs and potential stock rally.

Insider buying surge at SELLAS Life Sciences: over 900,000 shares bought by senior execs signals confidence, yet market sentiment lags—watch FDA milestones and earnings for a potential rally.